(C) Carac / ANSM 2014 - Dominique MartinDominique Martin to catalyze the French Agency for the Safety of Health Products

August 2014. Dominique Martin has been nominated Director-General of ANSM, the French Agency for the Safety of Health Products. He follows Dominique Maraninchi, a reputed cancerologist who is retiring end of August after steering ANSM since 2011. Mr. Martin at the top of the agency a proven public health functionary succeeds a dedicated scientist. He comes in at a time when France is plagued by weakened industry perfomance and rising unemployment, and the French socialist government pinning its hopes on the healthcare sector. ANSM is a building block in the strategem to re-launch the economy and soothe growing malaise among the different stakeholders in the country’s healthcare system: professional trade (doctors, pharmacists), healthcare providers (e.g. hospitals), public and private insurers, the medical device, pharmaceutical and other chemical industries as well as patient and consumer associations. Adding to high expectations are challenges at the European level to streamline transborder control, to harmonise regulations, and to support innovation in particular as related to SMEs.

Dr. Martin (1956) has obtained his MD with Specialty Psychiaty at Paris Hospitals and worked for Médecins Sans Frontières from 1984 to 1993. Thereafter he studied at École Nationale d’Administration (ENA) and obtained a diploma specialised in social sciences. In 1997 he joined the public administration as project manager (Chargé de mission) in the Ministry of Labour and Social Affairs initially for the Health Directorate and later for issues of minimum guaranteed income attached to Paris Prefecture until 1999. Thereafter he served as Technical Consultant to the State Secretary for the Aged and Handicapped, Dominique Gillot (Parti Socialiste) and Bernard Kouchner, co-founder of Médecins Sans Frontières and Deputy Minister of Health until 2002. That year Jacques Chirac (RPR) was elected president with a centre-right government. Mr. Martin became Head of the newly created Office national d’indemnisation des accidents médicaux, des affections iatrogènes et des infections nosocomiales (OMNIAM), a public administrative body to insure and manage claims of compensation in cases of medical accidents. After nine years he moved over to Caisse nationale d’assurance maladie des travailleurs salariés (CNAMTS) to direct the department for professional and occupational risks. CNAMTS is also a public administrative body but under joint authority of the Ministries Social Affairs and Economy. Its mission is to define national policy for health insurance.

Wolf G Kroner, Hervé Poiret contributed

Copyright Notice
Please note: You may freely distribute the link to this article. Any copying, distributing, or publishing of the entire article or parts of it (picture included) requires prior written consent by B2Bioworld or by third parties retaining copyrights. All rights reserved.

This editorial article is brought to you free of charge. You may see how we work, investigate issues,
and write up results in articles free of advertising and normally at cost. Enjoy reading

Back to section

Related Editorial Articles

Make or Break Drug Discovery and Biopharma of Merck Life Science
Relates also to Merck Bioproduct at Martillac, Aquitaine

Rallying Support for Post-2015 MDGs of the United Nations: Shenggen Fan honoured by Ban Ki-moon

Pharma Boost for Red Cross/Red Cre-scent’s Community Disease Prevention Programme

The Global Dimension of EU Health and Food Policies
Paola Testori-Coggi, at the time Director-General for Health and Consumers, European Commission

Diagnostic Microfluidics: Sample In – Results Out?
Marc Feiglin, former Chief Technology Officer Life Sciences at Tecan on electrowetting technology, blood diagnostic devices

WHO ECEH taps major donation and streamlines European operations

Metrics for Disease, Health, and Wellness
Personalized medicine? A systems look at human genetic diagnostics and the road ahead for next-generation sequencing by Leroy Hood, Institute for Systems Biology at Seattle

Sanofi: Triggering Regenerative Functions with Transplanted Cells and Small Molecules
Kurt Stoeckli, Global Head of Biological Sciences / Discovery Sanofi Aventis and Scientific Director of the research site at Vitry-Alfortville

Eurofins helps Pasteur de Lille out of the doldrums
An unmasked account of Institut Pasteur de Lille’s past failures and an assessment of the transaction

Physics <> Information <> Biology
A view from quantum optics. Interview with Alain Aspect, Professor of Physics at Institut d’Optique and Balzan Prize winner